A
AGOMAB THERAPEUTICS NV AMERICAN DEPOSITARY SHARES
NASDAQ: AGMB (AgomAb Therapeutics NV)
Last update: 1 hour ago7.49
-0.46 (-5.79%)
AIStockmoo Score
| Analyst Consensus | 2.3 |
| Insider Activity | 1.5 |
| Price Volatility | 3.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Relative Valuation | NA |
| Financial Health | NA |
| Macro Environment | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | 1.00 |
Select this tab to load the latest available analysis.
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Eqt Fund Management S.A R.L. | 30 Jun 2026 | 5,141,992 |
| Sanofi | 30 Jun 2026 | 2,783,096 |
| Redmile Group, Llc | 30 Jun 2026 | 2,733,926 |
| Cormorant Asset Management, Lp | 30 Jun 2026 | 2,465,348 |
| Tcg Crossover Management, Llc | 30 Jun 2026 | 2,053,233 |
| Federated Hermes, Inc. | 30 Jun 2026 | 1,618,000 |
| Nantahala Capital Management, Llc | 30 Jun 2026 | 1,568,188 |
| Casdin Capital, Llc | 30 Jun 2026 | 1,550,000 |
| Andera Partners | 30 Sep 2026 | 1,538,702 |
| Aberdeen Group Plc | 30 Jun 2026 | 846,695 |
| Perceptive Advisors Llc | 30 Jun 2026 | 600,000 |
| Samsara Biocapital, Llc | 30 Jun 2026 | 600,000 |
| Siren, L.L.C. | 30 Jun 2026 | 411,250 |
| Orbimed Advisors Llc | 30 Jun 2026 | 192,740 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 36.00 (Leerink Partners, 380.64%) | Buy |
| Median | 35.00 (367.29%) | |
| Low | 28.00 (Morgan Stanley, 273.83%) | Buy |
| Average | 33.00 (340.59%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 8.62 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Morgan Stanley | 26 Oct 2026 | 28.00 (273.83%) | Buy | 8.57 |
| H.C. Wainwright | 20 Oct 2026 | 35.00 (367.29%) | Buy | 8.73 |
| Leerink Partners | 02 Oct 2026 | 36.00 (380.64%) | Buy | 8.56 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| EPSTEIN DAVID R | 9.11 | - | 10,000 | 91,100 |
| Aggregate Net Quantity | 10,000 | |||
| Aggregate Net Value ($) | 91,100 | |||
| Aggregate Avg. Buy ($) | 9.11 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| EPSTEIN DAVID R | Director | 21 Oct 2026 | Buy (+) | 10,000 | 9.11 | 91,100 |
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |